The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Long Oligo Pool Synthesis for Capture Market Expected To Reach Based On Its 2026 Value?
The long oligo pool synthesis for capture market has seen rapid growth in recent years. Its value is expected to rise from $1.73 billion in 2025 to $1.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.7%. The expansion observed in the past can be ascribed to increased adoption of next generation sequencing, a greater need for targeted sequencing solutions, the broadening of cancer genomics research, the expanding application of gene panel testing, and breakthroughs in array based synthesis technologies.
The market size for long oligo pool synthesis for capture is predicted to undergo significant expansion in the coming years. It is projected to achieve a value of $3.31 billion by 2030, advancing at a compound annual growth rate (CAGR) of 13.9%. This expansion during the forecast period is attributable to several factors, including the surging demand for precision oncology applications, the escalating integration of AI-driven probe design tools, increasing investment in synthetic biology research, the widening scope of clinical genomic diagnostics, and the growing need for scalable and multiplexed enrichment methods. Prominent trends for the forecast period include the increasing uptake of high-plex target enrichment panels, a growing demand for custom capture probe libraries, rising integration of automated probe design platforms, the expansion of CRISPR screening applications, and an increasing focus on cost-effective, high-throughput oligo synthesis.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Drivers Are Fueling The Growth Of The Long Oligo Pool Synthesis for Capture Market?
The increasing need for personalized medical strategies is projected to boost the growth of long oligo pool synthesis for the capture market in the future. Precision medicine involves customizing disease prevention, diagnosis, and treatment for individual patients based on their distinct attributes. This demand for tailored medical approaches is escalating due to the expanded application of genomic sequencing, which facilitates more individualized and potent therapies. Long oligo pool synthesis for capture supports precision medicine by allowing for highly specific genomic enrichment and probe design, essential for targeted sequencing, identifying biomarkers, and categorizing patients in clinical and research settings. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the U.S. Food and Drug Administration (FDA) sanctioned 16 novel personalized treatments for rare disease patients in 2023, a considerable rise from the six approvals in 2022. Among these, seven were cancer medications, and three addressed other conditions. Consequently, the escalating requirement for precision medicine approaches is fueling the expansion of the long oligo pool synthesis for the capture market.
What Are The Different Segment Types In The Long Oligo Pool Synthesis for Capture Market Segment Breakdown?
The long oligo pool synthesis for capture market covered in this report is segmented –
1) By Product Type: Custom Capture Probe Libraries, Pre Designed Capture Panels, Capture Reagent Kits, Amplification And Enrichment Reagents, Design Software And Analytical Tools
2) By Synthesis Method: Array-Based Synthesis, Column-Based Synthesis, Microfluidic Synthesis, Other Synthesis Methods
3) By Application: Targeted Sequencing, Gene Synthesis, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening, Synthetic Biology, Other Applications
4) By End-Users: Academic And Research Institutes, Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Other End Users
Subsegments:
1) By Custom Capture Probe Libraries: Human Whole Exome Probe Libraries, Human Whole Genome Targeted Probe Libraries, Cancer Specific Gene Panel Probe Libraries, Inherited Disease Gene Panel Probe Libraries, Microbial And Pathogen Target Probe Libraries, Plant And Agricultural Genomics Probe Libraries, Custom Research Target Probe Libraries
2) By Pre Designed Capture Panels: Pan Cancer Gene Panels, Hereditary Disease Screening Panels, Pharmacogenomics Testing Panels, Immunology And Inflammation Panels, Neurology Related Disorder Panels, Cardiovascular Disease Panels, Metabolic Disorder Panels
3) By Capture Reagent Kits: Hybridization Buffer Reagent Kits, Washing And Elution Reagent Kits, Blocking Oligonucleotide Reagent Kits, Target Enrichment Reagent Kits, Library Preparation Reagent Kits, Quality Control Reagent Kits
4) By Amplification And Enrichment Reagents: Polymerase Based Amplification Reagents, Isothermal Amplification Reagents, Target Enrichment Bead Reagents, Adapter Ligation Reagents, Post Capture Amplification Reagents, Purification And Cleanup Reagents
5) By Design Software And Analytical Tools: Probe Design Software Platforms, Target Region Selection Tools, Sequencing Data Alignment Tools, Variant Detection Analysis Tools, Coverage And Quality Assessment Tools, Visualization And Reporting Tools
What Trends Are Shaping The Future Of The Long Oligo Pool Synthesis for Capture Market?
Leading companies within the long oligo pool synthesis for the capture market are increasingly forming strategic partnerships to accelerate the creation of highly complex custom oligo libraries for advanced genomic applications. These structured alliances allow organizations to leverage complementary strengths, expertise, and market access, thereby strengthening competitive advantage and supporting long-term, sustainable growth. For example, in January 2023, Twist Bioscience Corporation, a US-based biotechnology company, collaborated with Centogene N.V., a Germany-based diagnosis and research company specializing in rare diseases, to introduce three next-generation sequencing (NGS) target enrichment panels aimed at advancing rare disease and hereditary cancer research and diagnostics. These panels include the Twist Alliance CNTG Exome Panel for whole exome rare disease analysis, the CNTG Rare Disease Panel covering >2,500 genes for disorders like treatable rare diseases and metabolic issues, and the CNTG Hereditary Oncology Panel with 72 genes for cancer predisposition biomarkers. They were curated from CENTOGENE’s Biodatabank, which contains data from nearly 700,000 diverse patients, and synthesized by Twist to ensure precise variant detection.
Who Are The Well-Known Companies In The Long Oligo Pool Synthesis for Capture Market?
Major companies operating in the long oligo pool synthesis for capture market are Eurofins Genomics GmbH, Agilent Technologies Inc, BGI Genomics, GenScript Biotech Corporation, Twist Bioscience Corporation, Azenta Inc, DNA Script SAS, Synbio Technologies Inc, LGC Biosearch Technologies Inc, Bioneer Corporation, Gene Universal Inc, Ansa Biotechnologies Inc, Microsynth AG, Daicel Arbor Biosciences, iGeneTech Bioscience Co Ltd, Moligo Technologies AB, Creative Biogene LLC, SBS Genetech Co Ltd, MaxPrecision Labs Inc, Integrated DNA Technologies, Dynegene.
Get The Full Long Oligo Pool Synthesis for Capture Market Report:
Which Region Dominates The Long Oligo Pool Synthesis for Capture Market By Market Share?
North America was the largest region in the long oligo pool synthesis for capture market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long oligo pool synthesis for capture market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Long Oligo Pool Synthesis for Capture Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Long Oligo Pool Synthesis for Capture Market 2026, By The Business Research Company
adeno-associated virus (avv) vectors in gene therapy market report 2026
gastric cancer therapy market report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report
over the counter (otc) drugs market report 2026
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
